celularity.com
Get leads like Celularity — and thousands more
Build targeted lists by tech stack, traffic, and more
Celularity: The $400M Gamble on Cellular Immortality
A biotech veteran's bet on turning placental cells into a commercial juggernaut
While most biotech startups struggle to find product-market fit, Celularity is betting $400M on a bold thesis: that the placenta holds the key to regenerative medicine. This isn't just another cell therapy company—it's Bob Hariri's audacious attempt to industrialize biology itself.
"Celularity isn't just developing therapies—it's building a cellular manufacturing empire with a founder who literally wrote the book on placental biology."
The Founder's Credibility
Bob Hariri isn't a typical CEO. As a trauma surgeon and founder of Celularity, he authored seminal research on placental stem cells. This isn't a startup chasing buzzwords—it's built on decades of clinical experience. His dual expertise in surgery and biology gives Celularity a rare edge: they understand both the science and the surgical realities of implementation.
The Revenue Reality Check
Here's the provocative truth: $55M in revenue with $400M in funding suggests Celularity is still in 'scale or die' mode. With 6,657 monthly visits and a global rank of #2.9M, their web presence is surprisingly modest for a company this size. This isn't a consumer-facing biotech—it's a B2B medical device play where clinical data, not website traffic, drives valuation.
The recent CMS withdrawal of skin substitute coverage determinations is both a headwind and an opportunity. While it creates regulatory uncertainty, Celularity's CEO publicly commenting shows they're playing offense, not defense. Their partnership with DefEYE to expand into ophthalmology reveals a strategic pivot: diversifying beyond wound care into high-margin surgical markets.
- Core thesis: Placental-derived cells offer superior regenerative properties without ethical concerns of embryonic sources
- Strategic pivot: Moving from pure therapy to 'cellular manufacturing platform' with IP moats
- Market timing: $200B+ regenerative medicine market still fragmented; Celularity aims to be the 'Intel Inside' for cell therapies
- Risk factor: Heavy reliance on CMS reimbursement decisions creates regulatory concentration risk
The Bottom Line: A High-Stakes Cellular Bet
Celularity is either a $400M masterclass in biotech execution or a cautionary tale about overfunding in cellular medicine. With 284 employees and $55M in revenue, they're past the science experiment phase—but the next 18 months will determine if their placental platform can scale commercially. For investors and founders, watch the CMS decisions and ophthalmology partnerships: these are the catalysts that will make or break this cellular medicine play.
What tech stack does Celularity use?
How much traffic does Celularity get?
Traffic & Engagement
Rankings
Backlinks & Authority
Search Traffic
Top Organic Keywords
Where is Celularity's audience located?
What keywords does Celularity rank for?
5 keywordsHow is Celularity's SEO?
Meta Tags
Celularity – The Next Evolution in Cellular Medicine
H1 Tags
What is Celularity's revenue?
Who competes with Celularity?
Who works at Celularity?
Loading leads...
What do customers think of Celularity?
No Trustpilot reviews available for this company.
Frequently Asked Questions about Celularity
What is Celularity's Revenue?
How fast is Celularity growing?
How do people interact with Celularity?
How do people find Celularity?
Who uses Celularity?
What technologies does Celularity use?
Who are Celularity's competitors?
Export Data
Unlock all exports
Download CSVs, JSONs & full reports
How to contact Celularity?
Contact Information
Export celularity.com Data
Download the complete tech stack, analytics, leads, and company data for celularity.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.
Raw JSON Data
Click "Show" to view the raw API response data
About celularity.com
Company Overview
celularity.com Social Media
Contact celularity.com
Phone Numbers
Technology Stack
celularity.com uses 13 technologies across their website including Font Awesome, Google Fonts, PHP, WordPress, and more.
Fonts
Font Awesome, Google Fonts
Programming Languages
PHP
CMS
WordPress
Cloud & Hosting
Cloudflare
Analytics & Marketing
Google Analytics
Web Standards
RSS
Traffic & Audience
celularity.com receives approximately 6.7K monthly visitors and ranks #2,892,647 globally. The website has a bounce rate of 40% with visitors viewing an average of 2.0 pages per visit. Users spend an average of 0:11 on the site.
The majority of celularity.com's traffic comes from undefined, undefined, .
Frequently Asked Questions
What is celularity.com?
What technologies does celularity.com use?
What are celularity.com's social media accounts?
Is celularity.com hiring?
How popular is celularity.com?
Related Searches
This page provides publicly available information about celularity.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit celularity.com directly at https://celularity.com.